Reaction
Arteriovenous Fistula Thrombosis reporting signals
As of the last recalculation, Arteriovenous Fistula Thrombosis appears in 344 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is PARICALCITOL (PRR 120.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Paricalcitol | 26 | 120.4 | 120.6 |
| Epoetin Alfa | 18 | 97.0 | 97.1 |
| Sevelamer Carbonate | 10 | 54.2 | 54.3 |
| Darbepoetin Alfa | 38 | 47.8 | 47.9 |
| Atovaquone | 6 | 45.9 | 45.9 |
| Iron Sucrose | 7 | 45.3 | 45.4 |
| Calcitriol Capsules 0.25 Mcg | 14 | 44.0 | 44.0 |
| Calcitriol Capsules 0.5 Mcg | 14 | 44.0 | 44.0 |
| Calcitriol | 14 | 43.5 | 43.5 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 5 | 27.8 | 27.8 |
| Cinacalcet Hydrochloride | 18 | 24.6 | 24.6 |
| Eculizumab | 20 | 23.6 | 23.6 |
| Patiromer | 3 | 13.2 | 13.2 |